scholarly article | Q13442814 |
P356 | DOI | 10.3892/IJO.16.4.777 |
P698 | PubMed publication ID | 10717248 |
P50 | author | Paul Lorigan | Q32649737 |
P2093 | author name string | B W Hancock | |
R E Coleman | |||
M H Robinson | |||
L M El Helw | |||
P433 | issue | 4 | |
P921 | main subject | dexamethasone | Q422252 |
chemotherapy | Q974135 | ||
P304 | page(s) | 777-782 | |
P577 | publication date | 2000-04-01 | |
P1433 | published in | International Journal of Oncology | Q6051527 |
P1476 | title | VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma | |
P478 | volume | 16 |
Q41385777 | A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma |
Q58862182 | Effect of dexamethasone on voltage-gated K + channels in Jurkat T-lymphocytes |
Q37340395 | Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma |
Q35941074 | Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182-185. |
Search more.